NAII — Natural Alternatives International Share News
0.000.00%
Last trade - 00:00- $7.58m
- $18.88m
- $142.52m
Brief: Natural Alternatives Prevails In Federal Circuit Appeal On Carnosyn Beta-Alanine Patents
Brief: Natural Alternatives' Carnosyn Beta-Alanine Receives New Dietary Ingredient Status From The FDA
Brief: Natural Alternatives International Reports Q2 Earnings Per Share Of $0.31
Brief: Natural Alternatives International Q1 Earnings Per Share $0.37
Brief: Natural Alternatives International Says On Sept 30 Co Entered First Amendment To Loan Agreement With Kaged Muscle LLC
Brief: Natural Alternatives International Announces Q4 Sales of $39.2 Mln
Brief: Natural Alternatives International Appoints Vice President Of Carnosyn Brands
Brief: Natural Alternatives International Q3 Earnings Per Share $0.30
Brief: Natural Alternatives - Co Entered Into An Amendment Of Its Credit Facility With Wells Fargo Bank, National Association
Brief: Natural Alternatives International Posts Q2 Adj. Earnings Per Share $0.29
Brief: Natural Alternatives announces allowance of new U.S. sustained release beta-alanine patent application
Brief: Natural Alternatives International Q1 EPS $0.21
Brief: Natural Alternatives International reports Q4 earnings per share $0.23
Brief: Natural Alternatives International announces new multi-year exclusive manufacturing agreement with the Juice Plus+ Company
Brief: Natural Alternatives International announces extension of CarnoSyn beta-alanine license agreement with Nutrabolt LLC
Brief: Natural Alternatives International Inc announces SR Carnosyn receives GRAS affirmation
Brief: Natural Alternatives International announces extension of CarnoSyn beta-alanine intellectual property portfolio
Brief: Natural Alternatives International says board authorized a $2 mln increase to its stock repurchase plan
Brief: Natural Alternatives Q2 EPS $0.37